Table 2.
Echocardiography variables and blood flow measurements in the supplemented (GrSuppl) and the placebo group (GrP) before (pre-suppl vs. pre-placebo) and after (post-suppl vs. post-placebo) dietary intervention (mean ± SD).
| Variables | GrSuppl (n = 12) | GrP (n = 12) | p | ||
|---|---|---|---|---|---|
| Pre-suppl | Post-suppl | Pre-placebo | Post-placebo | Post-suppl vs. post-placebo | |
| LVM (g) | 219.0 ± 24.5 | 226.0 ± 25.5 | 231.8 ± 38.2 | 228.0 ± 34.5 | ns |
| LVMI (g/m2) | 116.0 ± 8.6 | 116.0 ± 10.8 | 122.0 ± 11.2 | 120.0 ± 18.0 | ns |
| IVSDd (mm) | 10.0 ± 1.3 | 10.6 ± 1.4 | 11.3 ± 0.6 | 11.4 ± 1.4 | ns |
| LVPWTd (mm) | 9.4 ± 1.1 | 9.9 ± 1.2 | 10.6 ± 0.7 | 11.0 ± 1.2 | ns |
| LVEF % | 62.6 ± 4.9 | 63.9 ± 4.8 | 64.6 ± 8.5 | 64.4 ± 5.5 | ns |
| HR [b/min] | 58.0 ± 8.0 | 56.0 ± 10.0 | 57.0 ± 8.0 | 58.0 ± 6.0 | ns |
| PWV (m•s−1) | 5.9 ± 1.1 | 6.3 ± 1.5 | 6.0 ± 1.3 | 5.8 ± 0.8 | ns |
| BAD (mm) | 4.1 ± 0.6 | 4.3 ± 0.6 | 4.3 ± 0.4 | 4.2 ± 0.7 | ns |
| FMD (mm) | 5.0 ± 0.5 | 5.0 ± 0.6 | 5.2 ± 0.3 | 5.0 ± 0.6 | ns |
LVM: left ventricular mass; LVMI: left ventricular mass index; IVSDd: interventricular septal thickness (in diastole), LVPWTd: left ventricular posterior wall thickness in diastole; LVEF: left ventricular ejection fraction, HR: heart rate, PWV: pulse wave velocity; BAD: brachial artery diameter, FMD: flow-mediated vasodilation